JSKN003 Combined Treatment of HER2-positive Gastric Cancer
Clinical trial NCT06998771 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06998771
- Sponsor
- Shanghai JMT-Bio Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-15
- Primary completion
- 2028-06-30
- Enrollment
- 153
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.